- Type
- not stated
- Format
- Tabular — coded claims and EHR records (diagnosis, lab, prescription, procedure, immunisation) delivered as per-criterion pass/fail/inconclusive determinations through API integration
- Volume
- Not stated on this page. Order-of-magnitude estimate: a national medical-plus-prescription claims network of this enterprise scale implies 10^10+ claim lines and comparable pharmacy dispense events annually, each longitudinally linked per patient; the eligibility product adds one pass/fail/inconclusive evaluation per patient per protocol criterion per screening run, so at production referral volumes this alone reaches 10^7-10^8 determinations a year. Request the licensable-network size and current vintage.
- Users
- N/A as registered users — a population-data asset, not an account product. The relevant denominator is the covered population behind the payer, provider and pharmacy networks, which at this enterprise scale (~4,900 employees, revenue range $749.6M) implies tens of millions of lives. Exact covered-life count is not printed on the product page — confirm with the data team.
- History
- 20 years
- Update frequency
- not stated
- Growth
- Active — current conference-circuit investment (an October 2026 AMCP Nexus banner with a booked-meeting funnel) built around an explicit strategy of extending from claims into chart/EHR data, alongside a broad and actively marketed four-cloud product estate. This is a mature, well-capitalised enterprise expanding the data estate rather than a startup seeking scale.
- Launched
- Underlying claims data business dates to roughly 2014 or earlier by firmographic signals and the site's own 2021 logo assets, i.e. the data network is well over a decade old. The Clinical Trial Eligibility Screener as a named product is far newer — part of the recent claims-into-chart expansion — plausibly 2023-2025.
- Delivery
- not stated
- Entity mapping
- not stated
- Sample
- not stated
- Point-in-time
- not stated
- Licence
- not stated